Article
Understanding the mechanisms of action of estrogen receptor mutations in metastatic breast cancer
2019-01-01
Abstract excerpt
Estrogen receptor (ER) is a key driver of breast cancer development and progression and is the target for endocrine therapies. Use of endocrine agents has contributed greatly to reductions in breast cancer mortality over the last three decades. However, many patients develop resistance to these therapies, for reasons that remain unclear. Recent studies have identified ESR1 (ER) mutations in metastatic breast cance...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 0819e0d2-dddb-56e6-838f-6252261ac201
- DOI
- 10.25560/87273
